Pregnancy and Use of Psychoactive Substances: The Influence of Representations of Care on Care.

NCT03567070 | Completed

• 1 other identifier: 17-050
• Study Type: interventional
• Target: 9
• Locations: 1 country
• Sites: 1

Brief Summary

It is observed that pregnant women using psychoactive substance (s) have a more random and more accidental pregnancy follow-up than women with no addictive problems. The consumption approach can be either omitted during the pregnancy monitoring, or entrusted to the course or more often in late pregnancy or occurs more brutally during delivery at the time of complications (neonatal or obstetric). In this context, health professionals are looking for levers that allow women to take appropriate care quickly. This difficulty of access to care questions us and all the more because the time of the pregnancy is a moment of important psychic reorganization conducive to modify its habits, to change its glance on its consumptions and thus to start a care concerning addiction. Invesigators hypothesize that this population has less access to medical care during pregnancy for fear of stigmatization by the health care provider. Invesigators propose a multicenter qualitative study based on individual clinical interviews to collect the testimony of women who used psychoactive substance (s) during their pregnancy. The purpose of this work is to identify ways to improve the multidisciplinary medical management of these women by focusing on the representations they can make care of.

Conditions

Pregnancy

Outcome Measures

Primary Outcomes (1)

• individual clinical interview

  qualitative study based on an individual clinical interview

  baseline

Study Arms (1)

qualitative study based on an individual clinical interview

OTHER

Other: qualitative study based on an individual clinical interview

Interventions

qualitative study based on an individual clinical interview OTHER

qualitative study based on an individual clinical interview

qualitative study based on an individual clinical interview

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: pregnancy
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Major patients
• Pregnant or having given birth since \<28 days
• Having used (whether declared or discovered incidentally) - regardless of the amount of psychoactive substance (s) during pregnancy: alcohol, and / or heroin or OST, and / or cannabis, and / or psychostimulants (cocaine, ecstasy, amphetamines)
• Followed or not in addictology during pregnancy

You may not qualify if:

• Minor patients
• Patients under legal protection (guardianship, guardianship)
• Linguistic obstacle
• Psychiatric pathology decompensated at the time of the meeting
• Women who only used tobacco regularly during pregnancy
• Women who have only regularly used psychoactive drugs and / or licit opiates (excluding prescription replacement products) during pregnancy

Sponsors & Collaborators

• University Hospital, Caen: lead

Study Sites (1)

Caen University Hospital

Caen, France

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 12, 2018
• First Posted: June 25, 2018
• Study Start: March 17, 2017
• Primary Completion: August 24, 2017
• Study Completion: June 12, 2018
• Last Updated: June 25, 2018

Record last verified: 2018-06

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)